139 related articles for article (PubMed ID: 25911900)
21. Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
Jiang N; Deng JY; Ding XW; Liu Y; Liang H
Eur J Surg Oncol; 2015 Mar; 41(3):315-22. PubMed ID: 25601610
[TBL] [Abstract][Full Text] [Related]
22. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
Zhang Y; Ma LW
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
[TBL] [Abstract][Full Text] [Related]
23. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis analysis of 310 patients with pathological stage pN3 gastric cancer].
Ke B; Liu N; Liang H; Zhang RP; Wang XJ; Wu LL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):543-6. PubMed ID: 23801207
[TBL] [Abstract][Full Text] [Related]
25. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
[TBL] [Abstract][Full Text] [Related]
27. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
28. High Ki67 Expression has Prognostic Value in Surgically-Resected T3 Gastric Adenocarcinoma.
Huang G; Chen S; Wang D; Wang R; Lin L; Chen S; Wang L; Huang Q
Clin Lab; 2016; 62(1-2):141-53. PubMed ID: 27012044
[TBL] [Abstract][Full Text] [Related]
29. Gastric cancer in the young: An advanced disease with poor prognostic features.
Rona KA; Schwameis K; Zehetner J; Samakar K; Green K; Samaan J; Sandhu K; Bildzukewicz N; Katkhouda N; Lipham JC
J Surg Oncol; 2017 Mar; 115(4):371-375. PubMed ID: 28008624
[TBL] [Abstract][Full Text] [Related]
30. Significance of palliative gastrectomy for late-stage gastric cancer patients.
Chen S; Li YF; Feng XY; Zhou ZW; Yuan XH; Chen YB
J Surg Oncol; 2012 Dec; 106(7):862-71. PubMed ID: 22648960
[TBL] [Abstract][Full Text] [Related]
31. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
[TBL] [Abstract][Full Text] [Related]
32. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
33. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.
Sougioultzis S; Syrios J; Xynos ID; Bovaretos N; Kosmas C; Sarantonis J; Dokou A; Tzivras D; Zografos G; Felekouras E; Papalambros E; Tsavaris N
Eur J Surg Oncol; 2011 Apr; 37(4):312-8. PubMed ID: 21300519
[TBL] [Abstract][Full Text] [Related]
34. The assessment of clinicopathological features, therapy pattern and survival benefit of 162 gastric cancers with liver metastases.
Li J; Lu M; Li J; Zhang X; Li Y; Zhan X; Shen L
Hepatogastroenterology; 2013 May; 60(123):628-32. PubMed ID: 23108083
[TBL] [Abstract][Full Text] [Related]
35. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
36. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in the surgical treatment of gastric cancer--10 years experience.
Káposztás Z; Kalmár K; Cseke L; Illényi L; Kelemen D; Horváth OP
Magy Seb; 2007 Apr; 60(2):71-8. PubMed ID: 17649847
[TBL] [Abstract][Full Text] [Related]
38. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
39. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
[TBL] [Abstract][Full Text] [Related]
40. Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer.
Lee SE; Lee JH; Ryu KW; Nam B; Kim CG; Park SR; Kook MC; Kim YW
Hepatogastroenterology; 2012; 59(114):430-5. PubMed ID: 22353511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]